drugset / Trial / NCT06822946
Zhibitai Capsules for the Treatment of Primary Hyperlipidemia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Exploring the benefit risk ratio of increase in dosage of Zhibitai capsules (2 capsules at a time, 2 times a day) compared to the original dosage (1 capsule at a time, 1 day)
Timeline
- Start
- 2025-03-27
- Primary completion
- 2026-02-28
- Completion
- 2026-04-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Zhibitai | Unknown | 1 unknown | Oral |
| Comparator | Zhibitai | Unknown | 2 unknown | Oral |